·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
¸¶ÀÌÆäÀÌÁö
ÃÖ±Ùº»»óǰ
MENU
Ä®¶ó±Â
°Ë»ö Æû
ÃÖ±Ù Á¶È¸ÇϽŠ»óǰ ¸ñ·Ï
ÃÖ±Ù Á¶È¸ÇϽŠ»óǰÀÌ ¾ø½À´Ï´Ù.
°ßÀû¹®ÀÇ
±Û¾²±â
À̸§
Á¦¸ñ
³»¿ë
°Ë»ö
°øÁö
¡Ø À§ÂÊ ±Û¾²±â ¹öưÀ» ´©¸£½Ã¸é ±Û¾²±â ¾ç½ÄÀÌ ³ª¿É´Ï´Ù.
°øÁö
ÇÐȸÆ÷½ºÅÍ ÁÖ¹®¿ä·É Âü°í
Ä®¶ó±Â | 2025-04-21
°øÁö
¡Ø ¾÷¹«º° ÀüÈ ¹× ¸ÞÀϾȳ»
Ä®¶ó±Â | 2023-10-27
°øÁö
ÅëÀå»çº» / »ç¾÷ÀÚµî·ÏÁõ»çº» ´Ù¿î·Îµå
Ä®¶ó±Â | 2019-10-23
[±âŸ] ½Ç»ç½ºÆ¼Ä¿ ÁÖ¹®ÇÕ´Ï´Ù.
±è¼±¿µ
| 2016-11-23
[±âŸ] ½Ç»ç½ºÆ¼Ä¿ ÁÖ¹®ÇÕ´Ï´Ù.
| 2016-11-24
[ÇÐȸÆ÷½ºÅÍ] Validity of Dabigatran or Rivaroxaban for Elderly Patients with Nonvalvular Atrial Fibrillation
Á¶¿µ¼÷
| 2016-11-23
[ÇÐȸÆ÷½ºÅÍ] Validity of Dabigatran or Rivaroxaban for Elderly Patients with Nonvalvular Atrial Fibrillation
| 2016-11-24
[Æûº¸µå.Æ÷¸Æ½ºº¸µå·ù] Æûº¸µå ±âŸ »çÀÌÁî °ßÀû ¹®ÀÇ
±è¹ÎÁö
| 2016-11-23
[Æûº¸µå.Æ÷¸Æ½ºº¸µå·ù] Æûº¸µå ±âŸ »çÀÌÁî °ßÀû ¹®ÀÇ
| 2016-11-23
[Á·ÀÚÆ÷½ºÅÍ] [ÁÖ¹®] °í±Þ ÆäÆ® Á·ÀÚ ÁÖ¹®
ÆÄ¶ó³ëÀ̵åÁ¶ÀÌ
| 2016-11-22
[Á·ÀÚÆ÷½ºÅÍ] [ÁÖ¹®] °í±Þ ÆäÆ® Á·ÀÚ ÁÖ¹®
| 2016-11-22
[¹è³Ê.Çö¼ö¸·] ¼Ò¸¸»ç 4°Ç ÀǷڵ帳´Ï´Ù
¼Ò¸¸»ç
| 2016-11-22
[¹è³Ê.Çö¼ö¸·] ¼Ò¸¸»ç 4°Ç ÀǷڵ帳´Ï´Ù
| 2016-11-22
±Û¾²±â
356
357
358
359
360